United Airlines' CEO Says Only a 'Handful' of Staff Have Resigned Over its Vaccine Mandate

Ginkgo Bioworks, a synthetic biology company now valued at around $15 billion, begins trading on the New York Stock Exchange today. Ginkgo’s market debut is one of the largest in biotech history. It’s expected to raise about $1.6 billion for the company. It’s also one of the biggest SPAC deals done to date — Ginkgo is going public through a merger with Soaring Eagle Acquisition Corp., which was an